Brain scan study aims to sharpen diagnosis of Parkinson's and dementia

NCT ID NCT01453127

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses a special brain scan called DaTscan to look at how certain brain diseases affect the brain. Researchers will scan 500 adults with conditions like Parkinson's disease, dementia, mild cognitive impairment, or REM sleep behavior disorder. The goal is to see if DaTscan can help doctors tell these conditions apart more accurately and improve understanding of how they develop.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
I-123 Ioflupane (DaTscan) injection
What this could lead to
If successful, this could improve how doctors diagnose and distinguish between different neurodegenerative diseases, leading to earlier and more accurate diagnoses.
What could go wrong
This is an observational imaging study, not a treatment trial. It may not directly change patient outcomes, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.